| Thursday, October 30, 2008 |
| 6:30 am - 6:00 pm |
Registration Open |
| 7:00 am - 8:00 am |
Continental Breakfast |
| 7:45 am - 7:50 am |
Welcome and Introduction
Bernard A. Fox, PhD, Earle A. Chiles Research Institute |
| 7:50 am - 8:15 am |
Keynote Address
Michael Karin, PhD, University of California, San Diego
|
| 8:15 am - 11:30 am |
State of the Science Plenary Sessions |
| 8:15 am - 8:45 am |
Defining Inflammation
| Co-Chairs: |
Michele Carbone, MD, PhD, Cancer Research Center of Hawaii
 Sandra Demaria, MD, New York University |
|
| 8:45 am - 9:15 am |
Genetic Polymorphisms and Factors which Modulate Inflammation and Cancer
| Co-Chairs: |
Yen-Ching Karen Chen, ScD, SM, National Taiwan University
Emad M. El-Omar, MB ChB, MD, University of Aberdeen
|
|
| 9:15 am - 9:45 am |
Animal Models of Cancer and Inflammation
| Co-Chairs: |
Lisa M. Coussens, PhD, University of California, San Francisco
Michael Karin, PhD, University of California, San Diego |
|
| 9:45 am - 10:00 am |
Break |
| 10:00 am - 10:30 am |
Causes and Molecular Targets in Cancer and Inflammation
| Co-Chairs: |
Michael T. Lotze, MD, University of Pittsburgh Cancer Institute
Giorgio Trinchieri, MD, National Cancer Institute |
|
| 10:30 am - 11:00 am |
Current Clinical Evidence for Targeting Inflammation to Prevent Cancer
| Co-Chairs: |
Steven Dubinett, MD, University of California, Los Angeles
Eva Szabo, MD, National Cancer Institute, NIH |
|
| 11:00 am - 11:30 am |
Novel Therapeutics and Clinical Trial Development to Treat Cancer
| Co-Chairs: |
Arthur M. Krieg, MD, Pfizer
George J. Weiner, MD, University of Iowa |
|
| 11:30 am - 12:00 pm |
Lunch |
| 12:00 pm - 1:30 pm |
Concurrent Breakout Sessions
(limited space available, pre-registration and ticket required) |
| |
| Breakout Session 1: | Defining Inflammation |
| Breakout Session 2: | Genetic Polymorphisms and Factors which Modulate Inflammation and Cancer |
| Breakout Session 3: | Animal Models of Cancer and Inflammation. |
| Breakout Session 4: | Causes and Molecular Targets in Cancer and Inflammation |
| Breakout Session 5. | Current Clinical Evidence for Targeting Inflammation to Prevent Cancer |
| Breakout Session 6. | Novel Therapeutics and Clinical Trial Development to Treat Cancer |
|
| 12:00 pm - 1:30 pm |
Concurrent Group Lecture: Abstract Presentations
| Co-Chairs: |
George Coukos, MD, PhD, University of Pennsylvania Medical Center
Ena Wang, MD, National Institutes of Health |
|
| 12:00 pm - 12:15 pm |
Recombinant Interleukin-21 Plus Sorafenib for Metastatic Renal Cell Carcinoma (MRCC): A Phase 1 Dose Escalation Study
Shailender Bhatia, MD, University of Washington |
| 12:15 pm - 12:30 pm |
The Genetic Background of IFNβ Responsiveness: A Genome-wide Study
Zoltan Pos, PhD, National Institutes of Health |
| 12:30 pm - 12:45 pm |
Arginase I Producing Myeloid Derived Suppressor cells (MDSC) in Renal cell Carcinoma are a Sub Population of Activated Granulocytes
Paulo C. Rodriguez, PhD, Louisiana State University Health Science Center |
| 12:45 pm - 1:00 pm |
RLIP76: A Target for Kidney cancer Therapy
Sanjay Awasthi, MD, University of North Texas Health Sciences Center |
| 1:00 pm - 1:15 pm |
Asbestos-Induced human Mesothelial Cell Death causes the Release if HMGBI abd Resultant Inflammation
Haining Yang, PhD, Cancer Research Center of Hawaii, John A Burns School of Medicine |
| 1:15 pm - 1:30 pm |
April Produced by Neutrophils Promotes Diffuse Large B-Cell Lymphoma Development
Bertrand Huard, PhD, Medical University Center |
| 1:30 pm - 2:00 pm |
Break |
| 2:00 pm - 2:30 pm |
Plenary Session: Industry Perspectives on Anti-inflammatory Therapy
Moderator: Bernard A. Fox, PhD, Earle A. Chiles Research Institute
Speaker: Robert T. Abraham, PhD, Wyeth
|
| 2:30 pm - 5:30 pm |
Reporting Session/Panel Discussion
Moderator: Michael T. Lotze, MD, University of Pittsburgh Cancer Institute |
| 2:30 pm - 3:00 pm |
Breakout 1 Report: Defining Inflammation
Michele Carbone, MD, PhD, Cancer Research Center of Hawaii |
| 3:00 pm - 3:30 pm |
Breakout 2 Report: Genetic Polymorphisms and Factors which Modulate Inflammation and Cancer
Emad M. El-Omar, MB ChB, MD, University of Aberdeen |
| 3:30 pm - 4:00 pm |
Breakout 3 Report: Animal Models of Cancer and Inflammation.
Lisa M. Coussens, PhD, University of California, San Francisco |
| 4:00 pm - 4:30 pm |
Breakout 4 Report: Causes and Molecular Targets in Cancer and Inflammation
Giorgio Trinchieri, MD, National Cancer Institute |
| 4:30 pm - 5:00 pm |
Breakout 5 Report: Current Clinical Evidence for Targeting Inflammation to Prevent Cancer
Steven Dubnielt, MD, University of california, Los Angeles |
| 5:00 pm - 5:30 pm |
Breakout 6 Report: Novel Therapeutics and Clinical Trial Development to Treat Cancer
George J. Weiner, MD, University of Iowa |
| 5:30 pm - 5:45 pm |
Closing Comment and Future Plans
Michael T. Lotze, MD, University of Pittsburgh Cancer Institute
|
